Pfizer plunges further into generics with Claris as new partner
This article was originally published in Scrip
Executive Summary
Pfizer is plunging deeper into the generics space through an expanded alliance with Aurobindo Pharma and the acquisition of rights to 15 injectable products from Claris Lifesciences, both Indian companies.